JBC Advanced Glycation Endproducts

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M505839200 on November 15, 2005

J. Biol. Chem., Vol. 281, Issue 10, 6136-6143, March 10, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/10/6136    most recent
M505839200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dekanty, A.
Right arrow Articles by de Asúa, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dekanty, A.
Right arrow Articles by de Asúa, L. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Leukemia Inhibitory Factor Induces DNA Synthesis in Swiss Mouse 3T3 Cells Independently of Cyclin D1 Expression through a Mechanism Involving MEK/ERK1/2 Activation*

Andres Dekanty{ddagger}, Moira Sauane{ddagger}, Belen Cadenas{ddagger}, Federico Coluccio§, Marcela Barrio{ddagger}, Jorgelina Casala{ddagger}, Mercedes Paciencia{ddagger}, Florencia Rogers{ddagger}1, Omar A. Coso§2, Graciela Piwien-Pilipuk{ddagger}2, Philip S. Rudland, and Luis Jiménez de Asúa{ddagger}234

From the {ddagger}Fundación Instituto Leloir, Av. Patricias Argentinas 435, 1405 Buenos Aires, Argentina, §Laboratorio de Fisiología y Biología Molecular, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, 1428 Buenos Aires, Argentina, and Molecular Medicine Group, School of Biological Sciences, University of Liverpool, Liverpool L69 3BX, United Kingdom

Leukemia inhibitory factor (LIF) and oncostatin M (OSM) induce DNA synthesis in Swiss 3T3 cells through common signaling mechanism(s), whereas other related cytokines such as interleukin-6 and ciliary neurotrophic factor do not cause this response. Induction of DNA replication by LIF or prostaglandin F2{alpha} (PGF2{alpha}) occurs, in part, through different signaling events. LIF and OSM specifically trigger STAT1 cytoplasmic to nuclear translocation, whereas PGF2{alpha} fails to do so. However, LIF and PGF2{alpha} can trigger increases in ERK1/2 activity, which are required for their mitogenic responses because U0126, a MEK1/2 inhibitor, prevents both ERK1/2 activation and induction of DNA synthesis by LIF or PGF2{alpha} treatment. PGF2{alpha} induces cyclin D expression and full phosphorylation of retinoblastoma protein. In contrast, LIF fails to promote increases in cyclin D mRNA/protein levels; consequently, LIF induces DNA synthesis without promoting full phosphorylation of retinoblastoma protein (Rb). However, both LIF and PGF2{alpha} increase cyclin E expression. Furthermore, LIF mitogenic action does not involve protein kinase C (PKC) activation, because a PKC inhibitor does not block this effect. In contrast, PKC activity is required for PGF2{alpha} mitogenic action. More importantly, the synergistic effect between LIF and PGF2{alpha} to promote S phase entry is independent of PKC activation. These results show fundamental differences between LIF- and PGF2{alpha}-dependent mechanism(s) that induce cellular entry into S phase. These findings are critical in understanding how LIF and other related cytokine-regulated events participate in normal cell cycle control and may also provide clues to unravel crucial processes underlying cancerous cell division.


Received for publication, May 27, 2005 , and in revised form, October 7, 2005.

* This work was supported in part by the Association for International Cancer Research Grant 099-018 (Scotland, UK) and Cancer and Polio Research Fund (Liverpool, UK) (to L. J. A. and P. S. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Recipient of a GlaxoSmithKline-Argentina fellowship.

2 Investigator of the National Research Council (CONICET) of Argentina.

4 Visiting Professor from the Royal Society of London, School of Biological Sciences University of Liverpool, Liverpool, UK.

3 To whom correspondence should be addressed: Fundación Instituto Leloir, Av. Patricias Argentinas 435, C1405BWE Buenos Aires, Argentina. Tel.: 54-11-5238-7500; Fax: 54-11-5238-7501; E-mail: Ljimeneza{at}leloir.org.ar.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
W. Li, C.-L. Wu, P. G. Febbo, and A. F. Olumi
Stromally Expressed c-Jun Regulates Proliferation of Prostate Epithelial Cells
Am. J. Pathol., October 1, 2007; 171(4): 1189 - 1198.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.